ReP USP - Resultado da busca

Filtros : "ICB-BMI" "Financiamento NIH" "Estados Unidos" Limpar

Filtros

Indexado em
Collaboration
Normalized affiliation
Non normalized affiliation
- university of paris, imagine institute, paris, france (2)
- allergy and clinical immunology unit, department of medicine, tel aviv sourasky medical center and sackler faculty of medicine, tel aviv, israel (1)
- center for biomedical research on rare diseases u759 (ciberer), isciii, barcelona, spain (1)
- comparative immunology group, school of biochemistry and immunology, trinity biomedical sciences institute, trinity college dublin, dublin, ireland (1)
- department of biomedicine and prevention, university of rome tor vergata, rome, italy (1)

Countries of institutions of collaboration
- bélgica (2)
- canadá (2)
- espanha (2)
- estados unidos (2)
- frança (2)

Artigo de periodico-carta/editorial
Harnessing Type I IFN immunity against SARS-CoV-2 with early administration of IFN-β (2021)
Vinh, Donald C. ; Abel, Laurent ; Bastard, Paul ; Cheng, Matthew P. ; Condino Neto, Antonio ; Gregersen, Peter K. ; Haerynck, Filomeen ; Cicalese, Maria-Pia ; Hagin, David; Palacín, Pere Soler ; Planas, Anna M. ; Pujol, Aurora ; Notarangelo, Luigi D. ; Zhang, Qian ; Su, Helen C. ; Casanova, Jean-Laurent ; Meyts, Isabelle
Source: Journal of Clinical Immunology. Unidade: ICB
Subjects: IMUNOLOGIA, IMUNIDADE, IMUNODEFICIÊNCIA DE VARIÁVEL COMUM, IMUNOGENÉTICA, COVID-19, INTERFERON TIPO I, INFECÇÕES POR CORONAVIRUS, ESTUDOS DE COORTES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VINH, Donald C. et al. Harnessing Type I IFN immunity against SARS-CoV-2 with early administration of IFN-β. Journal of Clinical Immunology. New York: Instituto de Ciências Biomédicas, Universidade de São Paulo. Disponível em: https://doi.org/10.1007/s10875-021-01068-6. Acesso em: 18 nov. 2024. , 2021
APA
Vinh, D. C., Abel, L., Bastard, P., Cheng, M. P., Condino Neto, A., Gregersen, P. K., et al. (2021). Harnessing Type I IFN immunity against SARS-CoV-2 with early administration of IFN-β. Journal of Clinical Immunology. New York: Instituto de Ciências Biomédicas, Universidade de São Paulo. doi:10.1007/s10875-021-01068-6
NLM
Vinh DC, Abel L, Bastard P, Cheng MP, Condino Neto A, Gregersen PK, Haerynck F, Cicalese M-P, Hagin D, Palacín PS, Planas AM, Pujol A, Notarangelo LD, Zhang Q, Su HC, Casanova J-L, Meyts I. Harnessing Type I IFN immunity against SARS-CoV-2 with early administration of IFN-β [Internet]. Journal of Clinical Immunology. 2021 ; 1-18.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1007/s10875-021-01068-6
Vancouver
Vinh DC, Abel L, Bastard P, Cheng MP, Condino Neto A, Gregersen PK, Haerynck F, Cicalese M-P, Hagin D, Palacín PS, Planas AM, Pujol A, Notarangelo LD, Zhang Q, Su HC, Casanova J-L, Meyts I. Harnessing Type I IFN immunity against SARS-CoV-2 with early administration of IFN-β [Internet]. Journal of Clinical Immunology. 2021 ; 1-18.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1007/s10875-021-01068-6
Artigo de periodico
A global effort to dissect the human genetic basis of resistance to SARS-CoV-2 infection (2021)
Andreakos, Evangelos ; Abel, Laurent ; Vinh, Donald C. ; Kaja, Elzbieta ; Drolet, Beth A. ; Zhang, Qian ; O\2019Farrelly, Cliona ; Novelli, Giuseppe ; Gallego, Carlos Rodríguez ; Haerynck, Filomeen ; Prando, Carolina ; Pujol, Aurora ; Condino Neto, Antonio ; Zatz, Mayana
Source: Nature Immunology. Unidades: ICB, IB
Subjects: IMUNOLOGIA, INFECÇÕES POR CORONAVIRUS, GENÉTICA MÉDICA, INTERFERON TIPO I, QUIMIOCINAS, PLASMODIUM
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ANDREAKOS, Evangelos et al. A global effort to dissect the human genetic basis of resistance to SARS-CoV-2 infection. Nature Immunology, p. 1-6, 2021Tradução . . Disponível em: https://doi.org/10.1038/s41590-021-01030-z. Acesso em: 18 nov. 2024.
APA
Andreakos, E., Abel, L., Vinh, D. C., Kaja, E., Drolet, B. A., Zhang, Q., et al. (2021). A global effort to dissect the human genetic basis of resistance to SARS-CoV-2 infection. Nature Immunology, 1-6. doi:10.1038/s41590-021-01030-z
NLM
Andreakos E, Abel L, Vinh DC, Kaja E, Drolet BA, Zhang Q, O\2019Farrelly C, Novelli G, Gallego CR, Haerynck F, Prando C, Pujol A, Condino Neto A, Zatz M. A global effort to dissect the human genetic basis of resistance to SARS-CoV-2 infection [Internet]. Nature Immunology. 2021 ; 1-6.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1038/s41590-021-01030-z
Vancouver
Andreakos E, Abel L, Vinh DC, Kaja E, Drolet BA, Zhang Q, O\2019Farrelly C, Novelli G, Gallego CR, Haerynck F, Prando C, Pujol A, Condino Neto A, Zatz M. A global effort to dissect the human genetic basis of resistance to SARS-CoV-2 infection [Internet]. Nature Immunology. 2021 ; 1-6.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1038/s41590-021-01030-z

Digital Library of Intellectual Production of Universidade de São Paulo 2012 - 2024